Publications

Results 1-115 of 115 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12021Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125Wang Y.-H.; Lin C.-C.; Hsu C.-L.; Hung S.-Y.; Yao C.-Y.; Lee S.-H.; Tsai C.-H.; Hou H.-A.; WEN-CHIEN CHOU ; Tien H.-F.Annals of Hematology33
22021Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLTsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; Lin, Liang-In; WEN-CHIEN CHOU ; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang; MING YAOBlood advances4
32020ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burdenWang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; WEN-CHIEN CHOU ; Tang J.-L.; Tien H.-F.Blood Cancer Journal22
42020Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclaxWang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; WEN-CHIEN CHOU ; Hou H.-A.; Tien H.-F.Annals of Hematology1920
52020False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administrationLiu W.-D.; Lin S.-W.; Shih M.-C.; Su C.-L.; Wang Y.-W.; Lin S.-C.; Lee Y.-F.; Huang H.-H.; WEN-CHIEN CHOU ; Wu U.-I.; Chen Y.-C.; Chang S.-C.Clinical Microbiology and Infection23
62020Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in miceLin C.-C.; Yao C.-Y.; Hsu Y.-C.; Hou H.-A.; Yuan C.-T.; Li Y.-H.; Kao C.-J.; Chuang P.-H.; Chiu Y.-C.; Chen Y.; WEN-CHIEN CHOU ; Tien H.-F.Oncogene43
72020The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromesHung S.-Y.; Lin C.-C.; Hsu C.-L.; Yao C.-Y.; Wang Y.-H.; Tsai C.-H.; Hou H.-A.; WEN-CHIEN CHOU ; Tien H.-F.British Journal of Haematology0
82020A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patientsWang Y.-H.; Lin C.-C.; Yao C.-Y.; Hsu C.-L.; Hou H.-A.; Tsai C.-H.; WEN-CHIEN CHOU ; Tien H.-F.Blood Advances55
92019Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patientsTsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; WEN-CHIEN CHOU ; Chen C.-Y.; Hou H.-A.; Tien H.-F.EBioMedicine1013
102019Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuriaSakurai M.; Jang J.H.; WEN-CHIEN CHOU ; Kim J.S.; Wilson A.; Nishimura J.-I.; Chiou T.-J.; Kanakura Y.; Lee J.W.; Okamoto S.International Journal of Hematology76
112019Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndromeHuang H.-H.; Chen F.-Y.; WEN-CHIEN CHOU ; Hou H.-A.; Ko B.-S.; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H.BMC Cancer1521
122019Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): An international study on 331 patientsChristen F.; Hoyer K.; Yoshida K.; Hou H.-A.; Waldhueter N.; Heuser M.; Hills R.K.; Chan W.; Hablesreiter R.; Blau O.; Ochi Y.; Klement P.; WEN-CHIEN CHOU ; Blau I.-W.; Tang J.-L.; Zemojtel T.; Shiraishi Y.; Shiozawa Y.; Thol F.; Ganser A.; L?wenberg B.; Linch D.C.; Bullinger L.; Valk P.J.M.; Tien H.-F.; Gale R.E.; Ogawa S.; Damm F.Blood4956
132019Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort studyLiu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; WEN-CHIEN CHOU ; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S.British Journal of Haematology22
142019Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentialsHsu Y.-C.; Chen T.-C.; Lin C.-C.; Yuan C.-T.; Hsu C.-L.; Hou H.-A.; Kao C.-J.; Chuang P.-H.; Chen Y.-R.; WEN-CHIEN CHOU ; Tien H.-F.Blood Advances79
152019Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AMLPerl A.E.; Martinelli G.; Cortes J.E.; Neubauer A.; Berman E.; Paolini S.; Montesinos P.; Baer M.R.; Larson R.A.; Ustun C.; Fabbiano F.; Erba H.P.; Di Stasi A.; Stuart R.; Olin R.; Kasner M.; Ciceri F.; WEN-CHIEN CHOU ; Podoltsev N.; Recher C.; Yokoyama H.; Hosono N.; Yoon S.-S.; Lee J.-H.; Pardee T.; Fathi A.T.; Liu C.; Hasabou N.; Liu X.; Bahceci E.; Levis M.J.New England Journal of Medicine232301
162019Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral TrialSmith C.C.; Levis M.J.; Perl A.E.; Martinelli G.; Neubauer A.; Berman E.; Montesinos P.; Baer M.R.; Larson R.A.; WEN-CHIEN CHOU ; Yokoyama H.; Recher C.; Yoon S.-S.; Hill J.E.; Rosales M.; Bahceci E.Blood69
172018The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndromeYang Y.-T.; Chiu Y.-C.; Kao C.-J.; Hou H.-A.; Lin C.-C.; Tsai C.-H.; Tseng M.-H.; WEN-CHIEN CHOU ; Tien H.-F.Blood Cancer Journal1113
182018Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsTien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; WEN-CHIEN CHOU ; Tien H.-F.European Journal of Haematology1213
192018Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationTefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; Tang J.-L.; WEN-CHIEN CHOU ; Lin C.-C.; Tsai C.-H.; Tien H.-F.; Hou H.-A.Mayo Clinic Proceedings1212
202018Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndromeHou H.-A.; Tsai C.-H.; Lin C.-C.; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Yao M.; Tang J.-L.; Tien H.-F.Blood Cancer Journal3337
212018Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPATien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; WEN-CHIEN CHOU ; Tien H.-F.Haematologica810
222018Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndromeLin M.-E.; Hou H.-A.; Tsai C.-H.; Wu S.-J.; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen C.-Y.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Tien H.-F.Clinical Epigenetics1516
232018Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeKo B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; WEN-CHIEN CHOU ; Tien H.-F.; Lee C.-C.; Tang J.-L.EBioMedicine1819
242018GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaTien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; WEN-CHIEN CHOU ; Tien H.-F.Blood Cancer Journal1319
252018Hepatitis B reactivation among 1962 patients with hematological malignancy in TaiwanChen C.-Y.; Tien F.-M.; Cheng A.; Huang S.-Y.; WEN-CHIEN CHOU ; Yao M.; Tang J.-L.; Tien H.-F.; Sheng W.-H.BMC Gastroenterology1515
262017Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemiaLin C.-C.; Hsu Y.-C.; Li Y.-H.; Kuo Y.-Y.; Hou H.-A.; Lan K.-H.; Chen T.-C.; Tzeng Y.-S.; Kuo Y.-Y.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Chiu Y.-C.; WEN-CHIEN CHOU ; Tien H.-F.Haematologica1920
272017Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromesWEN-CHIEN CHOU ; Yeh S.-P.; Hsiao L.-T.; Lin S.-F.; Chen Y.-C.; Chen T.-Y.; Laille E.; Galettis A.; Dong Q.; Songer S.; Beach C.L.Asia-Pacific Journal of Clinical Oncology32
282017The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse modelHsu Y.-C.; Chiu Y.-C.; Lin C.-C.; Kuo Y.-Y.; Hou H.-A.; Tzeng Y.-S.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Hsiao T.-H.; WEN-CHIEN CHOU ; Tien H.-F.Journal of Hematology and Oncology2120
292017Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemiaTsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; WEN-CHIEN CHOU ; Tien H.-F.Blood Cancer Journal1922
302017A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromesYao C.-Y.; Chen C.-H.; Huang H.-H.; Hou H.-A.; Lin C.-C.; Tseng M.-H.; Kao C.-J.; Lu T.-P.; WEN-CHIEN CHOU ; Tien H.-F.Blood Advances10
312017Aurora A and NF-κB survival pathway drive chemoresistance in acute myeloid leukemia via the TRAF-interacting protein TIFAWei T.-Y.W.; Wu P.-Y.; Wu T.-J.; Hou H.-A.; WEN-CHIEN CHOU ; Teng C.-L.J.; Lin C.-R.; Chen J.-M.M.; Lin T.-Y.; Su H.-C.; Huang C.-C.F.; Yu C.-T.R.; Hsu S.-L.; Tien H.-F.; Tsai M.-D.Cancer Research2325
322017Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemiaHou H.-A.; Lu J.-W.; Lin T.-Y.; Tsai C.-H.; WEN-CHIEN CHOU ; Lin C.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; Tang J.-L.; Gong Z.; Lin L.-I.; Tien H.-F.Blood cancer journal45
332017Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese populationChiang Y.-H.; Chang Y.-C.; Lin H.-C.; Huang L.; Cheng C.-C.; Wang W.-T.; Cheng H.-I.; Su N.-W.; Chen C.G.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; WEN-CHIEN CHOU ; Lim K.-H.; Kuo Y.-Y.Oncotarget7
342016Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemiaChiu Y.-C.; Tsai M.-H.; WEN-CHIEN CHOU ; Liu Y.-C.; Kuo Y.-Y.; Hou H.-A.; Lu T.-P.; Lai L.-C.; Chen Y.; Tien H.-F.; Chuang E.Y.Leukemia1919
352016Expression of CALR mutants causes mpl-dependent thrombocytosis in zebrafishLim K.-H.; Chang Y.-C.; Chiang Y.-H.; Lin H.-C.; Chang C.-Y.; Lin C.-S.; Huang L.; Wang W.-T.; Gon-Shen Chen C.; WEN-CHIEN CHOU ; Kuo Y.-Y.Blood Cancer Journal1213
362016Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaTsai C.-H.; Hou H.-A.; Tang J.-L.; Liu C.-Y.; Lin C.-C.; WEN-CHIEN CHOU ; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F.Leukemia6872
372016A three-gene expression-based risk score can refine the European LeukemiaNet AML classificationWilop S.; WEN-CHIEN CHOU ; Jost E.; Crysandt M.; Panse J.; Chuang M.-K.; Br?mmendorf T.H.; Wagner W.; Tien H.-F.; Kharabi Masouleh B.Journal of Hematology and Oncology1011
382016Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)Yao C.-Y.; Hou H.-A.; Lin T.-Y.; Lin C.-C.; WEN-CHIEN CHOU ; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Wu S.-J.; Liao X.-W.; Lin C.-T.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Li C.-C.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F.Oncotarget912
392016Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiationChiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; WEN-CHIEN CHOU ; Liu J.-H.; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H.Scientific Reports98
402016Characteristics of Taiwanese patients of PNH in the international PNH registryWEN-CHIEN CHOU ; Huang W.-H.; Wang M.-C.; Chang C.-S.; Yeh S.-P.; Chiou T.-J.; Chen Y.-C.; Lin T.-H.; Shen M.-C.; on behalf of the Taiwan PNH study groupThrombosis Journal5
412016Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemiaHou H.-A.; Liu C.-Y.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Tsai C.-H.; Lin C.-C.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Tien H.-F.Oncotarget5151
422015SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDSInoue D.; Kitaura J.; Matsui H.; Hou H.-A.; WEN-CHIEN CHOU ; Nagamachi A.; Kawabata K.C.; Togami K.; Nagase R.; Horikawa S.; Saika M.; Micol J.-B.; Hayashi Y.; Harada Y.; Harada H.; Inaba T.; Tien H.-F.; Abdel-Wahab O.; Kitamura T.Leukemia4943
432015A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patientsChuang M.-K.; Chiu Y.-C.; WEN-CHIEN CHOU ; Hou H.-A.; Chuang E.Y.; Tien H.-F.Leukemia3841
442015An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotypeChuang M.-K.; Chiu Y.-C.; WEN-CHIEN CHOU ; Hou H.-A.; Tseng M.-H.; Kuo Y.-Y.; Chen Y.; Chuang E.Y.; Tien H.-F.Oncotarget2124
452015Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysisLim K.-H.; Lin H.-C.; Chen C.G.S.; Wang W.-T.; Chang Y.-C.; Chiang Y.-H.; Lin C.-S.; Su N.-W.; Su Y.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU Clinica Chimica Acta2018
462015Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysisLim K.-H.; Chang Y.-C.; Gon-Shen Chen C.; Lin H.-C.; Wang W.-T.; Chiang Y.-H.; Cheng H.-I.; Su N.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU Blood Cancer Journal2019
472015High risk of hepatitis B reactivation among patients with acute myeloid leukemiaChen C.-Y.; Huang S.-Y.; Cheng A.; WEN-CHIEN CHOU ; Yao M.; Tang J.-L.; Tsay W.; Sheng W.-H.; Tien H.-F.PLoS ONE2217
482015Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adultsCheng C.-L.; Li C.-C.; Hou H.-A.; Fang W.-Q.; Chang C.-H.; Lin C.-T.; Tang J.-L.; WEN-CHIEN CHOU ; Chen C.-Y.; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Tien H.-F.BMC Cancer2525
492015High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in TaiwanTang J.-L.; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Wu S.-J.; Hou H.-A.; WEN-CHIEN CHOU ; Huang S.-Y.; Tsay W.; Chen Y.-C.; Chen Y.-C.; Chang S.-C.; Ko B.-S.; Tien H.-F.PLoS ONE3536
502015TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolutionHou H.-A.; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Blood Cancer Journal7481
512015Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective studyHuang S.-Y.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Hou H.-A.; WEN-CHIEN CHOU ; Chou S.-C.; Hsu S.-C.; Ko B.-S.; Lu H.-Y.; Tsay W.; Tien H.-F.PLoS ONE87
522015Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemiaChen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.PLoS ONE63
532015GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolutionHou H.-A.; Lin Y.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Lin C.-C.; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Annals of Hematology1314
542014The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expressionKuo Y.-Y.; Hou H.-A.; Chen Y.-K.; Li L.-Y.; Chen P.-H.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Liu C.-Y.; Tang J.-L.; Yao M.; Tien H.-F.Haematologica78
552014Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12Chen C.-Y.; Sheng W.-H.; Huang S.-Y.; WEN-CHIEN CHOU ; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F.; Hsueh P.-R.Journal of Antimicrobial Chemotherapy1212
562014Calreticulin mutation was rarely detected in patients with myelodysplastic syndromeHou H.-A.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Chen P.-H.; Tien H.-F.Leukemia77
572014Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cellsLee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Hou H.-A.; Hsiao M.; Tien H.-F.Journal of Leukocyte Biology1313
582014SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolutionLin C.-C.; Hou H.-A.; WEN-CHIEN CHOU ; Kuo Y.-Y.; Wu S.-J.; Liu C.-Y.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology2423
592014Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHou H.-A.; Kuo Y.-Y.; Tang J.-L.; WEN-CHIEN CHOU ; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology4848
602014Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantationsChou S.-C.; Tang J.-L.; Hou H.-A.; WEN-CHIEN CHOU ; Hu F.-C.; Chen C.-Y.; Yao M.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Tien H.-F.Leukemia Research1617
612014Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myelomaHuang S.-Y.; Lin C.-W.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; WEN-CHIEN CHOU ; Tsay W.; Chou S.-J.; Tien H.-F.Annals of Hematology3841
622014Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaHou H.-A.; Lin C.-C.; WEN-CHIEN CHOU ; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Leukemia5964
632014IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patientsYang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Kuo Y.-Y.; Huang S.-Y.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology1614
642014IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolutionLin C.-C.; Hou H.-A.; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.American Journal of Hematology5965
652013Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10Chen C.-Y.; Huang S.-Y.; Tang J.-L.; Tsay W.; Yao M.; Ko B.-S.; WEN-CHIEN CHOU ; Tien H.-F.; Hsueh P.-R.Journal of Antimicrobial Chemotherapy2120
662013Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute LeukemiaChen C.-Y.; Cheng A.; Huang S.-Y.; Sheng W.-H.; Liu J.-H.; Ko B.-S.; Yao M.; WEN-CHIEN CHOU ; Lin H.-C.; Chen Y.-C.; Tsay W.; Tang J.-L.; Chang S.-C.; Tien H.-F.PLoS ONE2828
672013Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosisChen C.-Y.; WEN-CHIEN CHOU ; Tsay W.; Tang J.-L.; Yao M.; Huang S.-Y.; Tien H.-F.BMC Cancer610
682013Higher lipocalin 2 expression may represent an independent favorable prognostic factor in cytogenetically normal acute myeloid leukemiaYang W.-C.; Lin P.-M.; Yang M.-Y.; Liu Y.-C.; Chang C.-S.; WEN-CHIEN CHOU ; Hsu J.-F.; Huang C.-T.; Cho S.-F.; Yu W.-H.; Lin S.-F.Leukemia and Lymphoma1314
692013Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionWu S.-J.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; WEN-CHIEN CHOU ; Yao M.; Huang S.-Y.; Ko B.-S.; Tsay W.; Tien H.-F.American Journal of Hematology3834
702013Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence - Clinical implication and comparison between the West and the EastWu S.-J.; Lin C.-T.; Huang S.-Y.; Lee F.-Y.; Liu M.-C.; Hou H.-A.; Chen C.-Y.; Ko B.-S.; WEN-CHIEN CHOU ; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F.Annals of Hematology119
712013Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaCheng C.-L.; Hou H.-A.; Lee M.-C.; Liu C.-Y.; Jhuang J.-Y.; Lai Y.-J.; Lin C.-W.; Chen H.-Y.; Liu F.-T.; WEN-CHIEN CHOU ; Chen C.-Y.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Tien H.-F.Blood4332
722012Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010Chen C.-Y.; Huang S.-Y.; Tsay W.; Yao M.; Tang J.-L.; Ko B.-S.; WEN-CHIEN CHOU ; Tien H.-F.; Hsueh P.-R.International Journal of Antimicrobial Agents2017
732012A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic MicroenvironmentChou S.-H.; Ko B.-S.; Chiou J.-S.; Hsu Y.-C.; Tsai M.-H.; Chiu Y.-C.; Yu I.-S.; Lin S.-W.; Hou H.-A.; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; WEN-CHIEN CHOU ; Tien H.-F.PLoS ONE1614
742012The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolutionWu S.-J.; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen C.-Y.; WEN-CHIEN CHOU ; Yao M.; Huang S.-Y.; Ko B.-S.; Tang J.-L.; Tsay W.; Tien H.-F.Blood10690
752012Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaKantarjian H.M.; Thomas X.G.; Dmoszynska A.; Wierzbowska A.; Mazur G.; Mayer J.; Gau J.-P.; WEN-CHIEN CHOU ; Buckstein R.; Cermak J.; Kuo C.-Y.; Oriol A.; Ravandi F.; Faderl S.; Delaunay J.; Lys?k D.; Minden M.; Arthur C.Journal of Clinical Oncology749695
762012Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remissionWEN-CHIEN CHOU ; Peng K.-Y.; Lei W.-C.; Ko B.-S.; Tsay W.; Kuo C.-H.; Tien H.-F.Leukemia1615
772012DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implicationsHou H.-A.; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Blood173166
782011Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemiaHou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; Tang J.-L.; Chen C.-Y.; WEN-CHIEN CHOU ; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Tien H.-F.British Journal of Cancer2424
792011CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemiaLin T.-C.; Hou H.-A.; WEN-CHIEN CHOU ; Ou D.-L.; Yu S.-L.; Tien H.-F.; Lin L.-I.Leukemia34
802011TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogeneticsWEN-CHIEN CHOU ; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Blood199197
812011Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic informationWEN-CHIEN CHOU ; Hou H.-A.; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Huang Y.-N.; Chao Y.-C.; Hsu C.-A.; Huang C.-F.; Tien H.-F.Annals of Oncology2626
822011Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remissionChen B.-B.; Hsu C.-Y.; Yu C.-W.; Hou H.-A.; Liu C.-Y.; Wei S.-Y.; WEN-CHIEN CHOU ; Tien H.-F.; Shih T.T.-F.Radiology3227
832011Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profileLin T.-C.; Jiang S.-S.; WEN-CHIEN CHOU ; Hou H.-A.; Lin Y.-M.; Chang C.-L.; Hsu C.-A.; Tien H.-F.; Lin L.-I.Journal of Molecular Diagnostics13
842011The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaWEN-CHIEN CHOU ; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Leukemia107
852011High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesCheng C.-L.; Hou H.-A.; Jhuang J.-Y.; Lin C.-W.; Chen C.-Y.; Tang J.-L.; WEN-CHIEN CHOU ; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.British Journal of Cancer1717
862010Psoas abscess caused by non-typhoid salmonella in a patient with severe aplastic anemiaKuo C.-C.; Ku S.-C.; Wang J.-T.; Tsai C.-W.; Wu V.-C.; WEN-CHIEN CHOU Yonsei Medical Journal33
872010Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutationWEN-CHIEN CHOU ; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Blood166166
882010Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsWEN-CHIEN CHOU ; Huang H.-H.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Blood141138
892010A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutationsWEN-CHIEN CHOU ; Huang Y.-N.; Huang C.-F.; Tseng M.-H.; Tien H.-F.Blood1010
902010Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemiaHou H.-A.; Shih T.T.F.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Yao M.; Huang S.-Y.; WEN-CHIEN CHOU ; Hsu C.-Y.; Tien H.-F.Haematologica1314
912010WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring systemHou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; WEN-CHIEN CHOU ; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.Blood103117
922009Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patientsWEN-CHIEN CHOU ; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F.Leukemia4343
932009AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterationsTang J.-L.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F.Blood230231
942009Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survivalShih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; WEN-CHIEN CHOU ; Hsu S.-C.; Tsay W.; Yu C.-W.; Hsu C.-Y.; Tien H.-F.; Yang P.-C.Blood6357
952008Marrow osteopontin level as a prognostic factor in acute myeloid leukaemiaLee C.-Y.; Tien H.-F.; Hou H.-A.; WEN-CHIEN CHOU ; Lin L.-I.British Journal of Haematology1413
962008Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemiaHou H.-A.; WEN-CHIEN CHOU ; Lin L.-I.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Yao M.; Chen C.-Y.; Tsay W.; Tien H.-F.Leukemia Research4946
972008Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITDHou H.-A.; WEN-CHIEN CHOU ; Lin L.-I.; Chen C.-Y.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; Tien H.-F.Leukemia4549
982007Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphomaWu S.-J.; WEN-CHIEN CHOU ; Ko B.-S.; Tien H.-F.Haematologica2728
992007Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutationsWEN-CHIEN CHOU ; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F.Leukemia8884
1002007Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemiaLee C.-Y.; Tien H.-F.; Hu C.-Y.; WEN-CHIEN CHOU ; Lin L.-I.British Journal of Cancer3930
1012007Erratum: A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias (Leukemia (2007) vol. 21 (2236) 10.1038/sj.leu.2404888)Lin L.-I.; Lin T.-C.; WEN-CHIEN CHOU ; Tang J.-L.; Lin D.-T.; Tien H.-F.Leukemia2
1022007RUNX1 gene mutation in primary myelodysplastic syndrome - The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcomeChen C.-Y.; Lin L.-I.; Tang J.-L.; Ko B.-S.; Tsay W.; WEN-CHIEN CHOU ; Yao M.; Wu S.-J.; Tseng M.-H.; Tien H.-F.British Journal of Haematology106100
1032006A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias [8]Lin L.-I.; Lin T.-C.; WEN-CHIEN CHOU ; Tang J.-L.; Lin D.-T.; Tien H.-F.Leukemia3938
1042006Clinical implications of SOCS1 methylation in myelodysplastic syndromeWu S.-J.; Yao M.; WEN-CHIEN CHOU ; Tang J.-L.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; Tien H.-F.British Journal of Haematology3529
1052006Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolutionWEN-CHIEN CHOU ; Tang J.-L.; Lin L.-I.; Yao M.; Tsay W.; Chen C.-Y.; Wu S.-J.; Huang C.-F.; Chiou R.-J.; Tseng M.-H.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Tien H.-F.Cancer Research143136
1062005Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidationWEN-CHIEN CHOU ; Chen H.-Y.; Yu S.-L.; Cheng L.; Yang P.-C.; Dang C.V.Blood6559
1072005Acute promyelocytic leukemia: Recent advances in therapy and molecular basis of response to arsenic therapiesWEN-CHIEN CHOU ; Dang C.V.Current Opinion in Hematology6861
1082004Chromosomal abnormalities of 200 Chinese patients with non-Hodgkins's lymphoma in Taiwan: With special reference to T-cell lymphomaChen C.-Y.; Yao M.; Tang J.-L.; Tsay W.; Wang C.-C.; WEN-CHIEN CHOU ; Su I.-J.; Lee F.-Y.; Liu M.-C.; Tien H.-F.Annals of Oncology3830
1092004Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cellsWEN-CHIEN CHOU ; Jie C.; Kenedy A.A.; Jones R.J.; Trush M.A.; Dang C.V.Proceedings of the National Academy of Sciences of the United States of America178167
1102001Arsenic inhibition of telomerase transcription leads to genetic instabilityWEN-CHIEN CHOU ; Hawkins A.L.; Barrett J.F.; Griffin C.A.; Dang C.V.Journal of Clinical Investigation106103
1111998Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemiaHuang S.-Y.I.; Chang C.-S.; Tang J.-L.; Tien H.-F.; Kuo T.-L.I.; Huang S.-F.; Yao Y.U.-T.; WEN-CHIEN CHOU ; Chung C.-Y.; Wang C.-H.; Shen M.-C.; Chen Y.-C.British Journal of Haematology9798
1121998Clonal disease of natural killer large granular lymphocytes in TaiwanWEN-CHIEN CHOU ; Chiang I.-P.; Tang J.-L.; Su I.-J.; Huang S.-Y.I.; Chen Y.-C.; Liu M.-C.; Lee F.-Y.U.; Wang C.-H.; Shen M.-C.; Chuang S.-M.; Tien H.-F.British Journal of Haematology1411
1131997Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans-retinoic acid treatmentWEN-CHIEN CHOU ; Tang J.-L.; Yao M.; Liang Y.-J.; Lee F.-Y.; Lin M.-T.; Wang C.-H.; Shen M.-C.; Chen Y.-C.; Tien H.-F.Leukemia4641
1141996Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: Special emphasis on the tumor response to 13-cis retinoic acidWEN-CHIEN CHOU ; Su I.-J.; Tien H.-F.; Liang D.-C.; Wang C.-H.; Chang Y.-C.; Cheng A.-L.Cancer41
1151995Hypovolemic shock and mortality after ingestion of Tripterygium wilfordii hook F.: a case reportWEN-CHIEN CHOU ; Wu C.-C.; Yang P.-C.; Lee Y.-T.International Journal of Cardiology4636